Akazawa Manabu, Sato Takahiro, Ebata Nozomi, LoPresti Michael, Nishi Ryosuke
Department of Public Health and Epidemiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.
Medical Affairs, Rare Disease, Pfizer Japan Inc, Shibuya-ku, Tokyo, Japan.
Patient Prefer Adherence. 2024 Mar 8;18:607-622. doi: 10.2147/PPA.S446649. eCollection 2024.
About one-third of caregivers of pediatric or adolescent growth hormone deficiency (pGHD) patients in Japan have reported poor treatment adherence. However, few studies have examined factors related to adherence for that group.
The aim of this study is to consider factors related to poor adherence to daily treatment among caregivers of pGHD patients in Japan.
A cross-sectional survey was conducted among caregivers of pGHD patients in Japan. Caregivers were asked about demographic and treatment characteristics, health literacy, treatment satisfaction, opinions about treatment, and treatment adherence. Health literacy was assessed using the 14-item health literacy scale (HLS-14). Adherence was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8). Statistical association with adherence was considered using Chi-square and Student's -testing. An exploratory factor analysis (EFA) and K-means cluster analysis was conducted to consider the influence of treatment satisfaction and opinions concerning treatment on adherence.
Responses were collected from 112 caregivers. The caregiver's age being 30-39 years old, the primary caregiver being male, the primary caregiver being employed, and low functional health literacy for the caregiver were associated with poor adherence. Patients being pre-elementary school age was also associated with poor adherence. Low satisfaction with drug treatment and/or their device and communication with healthcare professionals (HCPs), and lack of agreement with the importance of treatment management (eg, keeping injection records, getting informed about the disease/therapy, reporting non-adherence, and sticking to an administration schedule), were also associated with poor adherence.
Strategies to improve treatment adherence among caregivers of pGHD patients in Japan should consider the age, gender, and employment status of the caregiver - as well as their functional literacy. Improvement in satisfaction with the drug or device used, better communication with HCPs, and greater awareness of the importance of treatment management, may also lead to better adherence.
在日本,约三分之一的儿童或青少年生长激素缺乏症(pGHD)患者的照料者报告称治疗依从性较差。然而,很少有研究探讨该群体与依从性相关的因素。
本研究旨在探讨日本pGHD患者照料者日常治疗依从性差的相关因素。
对日本pGHD患者的照料者进行了一项横断面调查。询问照料者有关人口统计学和治疗特征、健康素养、治疗满意度、对治疗的看法以及治疗依从性等问题。使用14项健康素养量表(HLS - 14)评估健康素养。使用8项Morisky药物依从性量表(MMAS - 8)评估依从性。采用卡方检验和学生t检验分析与依从性的统计学关联。进行探索性因素分析(EFA)和K均值聚类分析,以探讨治疗满意度和对治疗的看法对依从性的影响。
收集了112名照料者的回复。照料者年龄在30 - 39岁、主要照料者为男性、主要照料者有工作以及照料者的功能性健康素养较低与依从性差相关。患者为学龄前儿童也与依从性差相关。对药物治疗和/或其设备不满意、与医护人员(HCPs)沟通不畅,以及不同意治疗管理的重要性(如保存注射记录、了解疾病/治疗信息、报告不依从情况以及坚持给药时间表),也与依从性差相关。
提高日本pGHD患者照料者治疗依从性的策略应考虑照料者的年龄、性别和就业状况以及他们的功能性素养。提高对所用药物或设备的满意度、改善与HCPs的沟通以及增强对治疗管理重要性的认识,也可能导致更好的依从性。